Modern Chinese Medicine Group (1643) Delays Dispatch of Circular for Major Transaction

Bulletin Express
02/09

Modern Chinese Medicine Group Co., Ltd. (Stock Code: 1643) previously announced on 19 January 2026 that it would issue a circular regarding its major transaction involving the acquisition of sale shares. The announcement indicated that the circular would be distributed on or before 9 February 2026 in accordance with Rule 14.41(a) of the Listing Rules.

The company has now stated that additional time is required to finalize information, including the consolidated audited report of the target group for the three years ended 31 December 2025. Consequently, the expected dispatch date for the circular has been delayed to on or before 30 April 2026.

The company has applied for a waiver from strict compliance with Rule 14.41(a) of the Listing Rules; however, the Stock Exchange has not yet granted the waiver as of the date of the announcement. The company will provide further updates as appropriate.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10